How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Vijoice cost savings if eligible
If you are eligible for the Vijoice patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your XXXX through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Vijoice patient assistance program?
You could receive your Vijoice without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Vijoice patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Vijoice.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Vijoice patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Vijoice medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx a Vijoice coupon provider?
At NiceRx, we help eligible individuals access the Vijoice patient assistance program. This means that we are not a Vijoice coupon, a Vijoice discount card, or a Vijoice copay card provider. We do not offer any medication trial offers or free Vijoice samples.
Can NiceRx help me get Vijoice cheaper if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Vijoice medication, or if you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Vijoice cost without insurance?
Vijoice costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Vijoice oral tablets (200 mg-50 mg) will typically cost around $34,200 for 56 tablets. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Vijoice cost with insurance?
The copay of Vijoice will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Vijoice?
Vijoice is an FDA (U.S. Food and Drug Administration) approved medication distributed by Novartis Pharmaceuticals Corporation. Vijoice (alpelisib) is a kinase inhibitor used to treat the symptoms of breast cancer and rare overgrowth conditions caused by the effects of PIK3CA mutations in adults and children 2 years of age and older with PIK3CA-Related Overgrowth Spectrum (PROS).
FDA approval for Vijoice was based on real-world evidence from EPIK-P1, a retrospective chart review study. In accordance with the Accelerated Approval Program, continued approval for Vijoice may be based upon verification and description of clinical benefit from confirmatory trials.
What doses of Vijoice are available?
Vijoice is available in tablet form, in the following doses: 50mg.
The usual dose for the treatment of adult patients with severe manifestations of PIK3CA-Related Overgrowth Spectrum who require systemic therapy is 250 mg, orally once daily with food.
The usual dose for pediatric patients with severe manifestations of PIK3CA-Related Overgrowth Spectrum who require systemic therapy is 50 mg orally once daily with food.
Administer the recommended dose until disease progression or unacceptable toxicity. Please read the full prescribing information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Vijoice active ingredients
Vijoice contains alpelisib as the active ingredient.
Vijoice side effects
The most common side effects of Vijoice in clinical trials include:
- High blood sugar
- Dry skin
- Stomatitis (mouth sores)
- Hair loss (alopecia)
- Grade 3 or 4 laboratory abnormalities – increased glucose, decreased hemoglobin, decreased phosphate, increased bilirubin, decreased sodium, and decreased platelets
In rare instances, Vijoice can cause more serious adverse events. These can include:
- Severe allergic reactions
- Severe skin reactions
- High blood sugar levels (hyperglycemia)
- Lung problems (pneumonitis)
- Severe diarrhea leading to the loss of too much body water (dehydration) and kidney injury
Your doctor will assess the benefits of using Vijoice against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Vijoice to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Vijoice drug interactions
Vijoice can interact with other medications. These include:
- Strong CYP3A4 inducers
- Breast cancer resistance protein inhibitors (BCRP)
- CYP2C9 substrates
This list is not exhaustive and other prescription drugs may interact with Vijoice.
You should not use Vijoice if you:
- Are allergic to the active ingredient alpelisib
- Are allergic to any of the other ingredients in Vijoice
- Are pregnant or are planning to become pregnant – use effective birth control during treatment, and for 1 week after the last dose
Talk to your doctor before using Vijoice if you:
- Are taking any of the medications that could interact with Vijoice
- Have a history of diabetes
- Have a history of skin rash, redness of skin, blistering of the lips, eyes, or mouth, or skin peeling
- Are breastfeeding or are planning to breastfeed – Do not breastfeed during treatment, and for 1 week after the last dose
Vijoice is the trademark brand name for alpelisib distributed by Novartis Pharmaceuticals Corporation. A generic version of alpelisib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Vijoice savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.